Literature DB >> 8552992

C3 is activated in hereditary angioedema, and C1/C1-inhibitor complexes rise during physical stress in untreated patients.

E W Nielsen1, H T Johansen, O Gaudesen, B Osterud, J O Olsen, K Høgåsen, C E Hack, T E Mollnes.   

Abstract

Seven patients with hereditary angioedema (HAE) were studied to understand further how physical exercise may induce attacks. The most pronounced differences between patients and controls, however, were independent of the controlled bicycle run (mean values in patients/ controls); C4(g/L): 0.12/0.28 (P = 0.0122); C4bc (AU/ml): 137.0/18.0 (P = 0.0002); C4d (mg/mL): 5.03/2.35 (P = 0.0004); C3bc (AU/ml): 8.4/6.3 (P = 0.0049); C3a (AU/ml): 11.1/5.6 (P = 0.0102). The ratio C4bc to C4 was 1141 versus 64. Consequently, a substantial part of the low amount of C4 left in HAE patients consists of activation products, and the authors show for the first time that a mild but significant activation of C3 occurs in HAE. The two HAE patients treated with danazol had values of C1-INH function and antigen, C4, and C2 in-between those of normal and untreated patients, and lower levels of split products from C4 and high molecular weight kininogen than untreated patients. As a result of the exercise, fibrinolysis increased significantly in both patients and controls, while C1/C1-INH complexes rose significantly only in the five HAE patients without treatment when compared to the seven controls (P = 0.0089). This study thus suggests that complement activation is enhanced in untreated HAE patients following physical stress.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8552992     DOI: 10.1111/j.1365-3083.1995.tb03711.x

Source DB:  PubMed          Journal:  Scand J Immunol        ISSN: 0300-9475            Impact factor:   3.487


  7 in total

1.  Hereditary and acquired angioedema: problems and progress: proceedings of the third C1 esterase inhibitor deficiency workshop and beyond.

Authors:  Angelo Agostoni; Emel Aygören-Pürsün; Karen E Binkley; Alvaro Blanch; Konrad Bork; Laurence Bouillet; Christoph Bucher; Anthony J Castaldo; Marco Cicardi; Alvin E Davis; Caterina De Carolis; Christian Drouet; Christiane Duponchel; Henriette Farkas; Kálmán Fáy; Béla Fekete; Bettina Fischer; Luigi Fontana; George Füst; Roberto Giacomelli; Albrecht Gröner; C Erik Hack; George Harmat; John Jakenfelds; Mathias Juers; Lajos Kalmár; Pál N Kaposi; István Karádi; Arianna Kitzinger; Tímea Kollár; Wolfhart Kreuz; Peter Lakatos; Hilary J Longhurst; Margarita Lopez-Trascasa; Inmaculada Martinez-Saguer; Nicole Monnier; István Nagy; Eva Németh; Erik Waage Nielsen; Jan H Nuijens; Caroline O'grady; Emanuela Pappalardo; Vincenzo Penna; Carlo Perricone; Roberto Perricone; Ursula Rauch; Olga Roche; Eva Rusicke; Peter J Späth; George Szendei; Edit Takács; Attila Tordai; Lennart Truedsson; Lilian Varga; Beáta Visy; Kayla Williams; Andrea Zanichelli; Lorenza Zingale
Journal:  J Allergy Clin Immunol       Date:  2004-09       Impact factor: 10.793

2.  Experimental protocol of dental procedures In patients with hereditary angioedema: the role of anxiety and the use of nitrogen oxide.

Authors:  A Rosa; M Miranda; R Franco; M G Guarino; A Barlattani; P Bollero
Journal:  Oral Implantol (Rome)       Date:  2016-11-13

3.  Knockdown of circulating C1 inhibitor induces neurovascular impairment, glial cell activation, neuroinflammation, and behavioral deficits.

Authors:  Dorit Farfara; Emily Feierman; Allison Richards; Alexey S Revenko; Robert A MacLeod; Erin H Norris; Sidney Strickland
Journal:  Glia       Date:  2019-03-18       Impact factor: 7.452

4.  [Hereditary angioedema. Diagnostic and treatment errors as systemic lupus erythematosus].

Authors:  P Harten; D Körbächer; C Renk; H H Euler; H Löffler
Journal:  Med Klin (Munich)       Date:  1999-06-15

5.  Depressed activation of the lectin pathway of complement in hereditary angioedema.

Authors:  L Varga; G Széplaki; J Laki; A Kocsis; K Kristóf; P Gál; Z Bajtay; J Wieslander; M R Daha; P Garred; H O Madsen; G Füst; H Farkas
Journal:  Clin Exp Immunol       Date:  2008-05-05       Impact factor: 4.330

6.  Complement 1 inhibitor is a regulator of the alternative complement pathway.

Authors:  H Jiang; E Wagner; H Zhang; M M Frank
Journal:  J Exp Med       Date:  2001-12-03       Impact factor: 14.307

7.  Patterns of C1-Inhibitor/Plasma Serine Protease Complexes in Healthy Humans and in Hereditary Angioedema Patients.

Authors:  Erika Kajdácsi; Zsófia Jandrasics; Nóra Veszeli; Veronika Makó; Anna Koncz; Dominik Gulyás; Kinga Viktória Köhalmi; György Temesszentandrási; László Cervenak; Péter Gál; József Dobó; Steven de Maat; Coen Maas; Henriette Farkas; Lilian Varga
Journal:  Front Immunol       Date:  2020-05-05       Impact factor: 7.561

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.